Grant to help develop avian flu antibodies

Grant to help develop avian flu antibodies

OUTBREAKS of avian influenza virus in poultry usually result in the destruction of affected flocks within a five-mile radius.

However, research conducted by Dr. David Bradley, an immunologist at the University of North Dakota School of Medicine & Health Sciences, has shown that antibodies developed in goose eggs could be very effective in combatting avian flu, according to an announcement from the university.

Bradley recently received a Centers of Research Excellence grant of $700,000 from the North Dakota Department of Commerce to continue research on avian influenza antibodies that could help poultry farmers effectively combat outbreaks of the disease.

According to the university, Bradley's laboratory is working collaboratively on the project with Avianax LLC, a local company that develops antibodies for human and animal diseases such as West Nile virus and avian flu. Avianax is providing a two-to-one cash match for this research to develop the therapeutic avian flu antibody.

Avianax, a joint venture between Intraglobal Biologics and the University of North Dakota Research Foundation, was created to investigate the properties of goose antibodies and how they can be utilized as a platform for therapeutic and prophylactic treatment of various viral diseases.

With the help of this North Dakota grant, Bradley and Avianax hope to develop commercially viable therapeutic treatments within 12-18 months.


Volume:85 Issue:01

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.